Antibe Announces Granting of Initial Order Under Companies’ Creditors Arrangement Act
TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that its previously... Read more.
NEC Showcases Proven Biometric Solutions at Passenger Terminal Expo 2024
IRVING, Texas–(BUSINESS WIRE)–NEC Corporation of America (NEC), a leading provider and integrator of advanced IT, biometrics, communications and networking... Read more.
AUTODESK INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Autodesk, Inc. Investors to Inquire About Securities Class Action Investigation – ADSK
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf... Read more.
Ferronova – Nanoparticle Trial Begins in Patients With Gastric and Oesophageal Cancers
ADELAIDE, Australia–(BUSINESS WIRE)–Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace®... Read more.
GIP Australia Fund II Announces A$4.0 Billion Final Closing
NEW YORK–(BUSINESS WIRE)–Global Infrastructure Partners (“GIP”), a leading infrastructure investor, announced today that the GIP Australia Fund II... Read more.
CMD Global Partners Expands Corporate Advisory Practice in New York and Chicago
CHICAGO–(BUSINESS WIRE)–CMD Global Partners (“CMD”), an independent investment banking advisory firm, announced today that Alexandre Chenesseau and... Read more.
STEP Energy Services Ltd. to Announce First Quarter 2024 Results and Host Conference Call
CALGARY, Alberta–(BUSINESS WIRE)–STEP Energy Services Ltd. (“STEP”) intends to release its 2024 first quarter results on Wednesday, May 8, 2024 after... Read more.
MoneyLion to Announce First Quarter 2024 Financial Results on Tuesday, May 7, 2024
NEW YORK–(BUSINESS WIRE)–MoneyLion Inc. (“MoneyLion”) (NYSE: ML), a leader in financial technology powering the next generation of personalized products... Read more.
Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment
Tumor-directed N17350 and systemically delivered N17465 are based on the breakthrough discovery of a novel innate immune mechanism of action, which activates cell... Read more.
Independent Bank Group, Inc. Announces Date for Q1 2024 Earnings Call
MCKINNEY, Texas–(BUSINESS WIRE)–Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Financial, will hold a conference call... Read more.